NONCLASSICAL ANTIMETABOLITES .16. BRIDGE PRINCIPLE OF SPECIFICITY WITH ACTIVE SITE-DIRECTED IRREVERSIBLE INHIBITORS .7. DETECTION OF DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES BY MALEAMYL GROUP

被引:4
作者
BAKER, BR
ALUMAULA, PI
机构
关键词
D O I
10.1002/jps.2600520926
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:914 / &
相关论文
共 14 条
[1]  
BAKER BH, TO BE PUBLISHED
[2]   NON-CLASSICAL ANTIMETABOLITES .6. 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR [J].
BAKER, BR ;
LEE, WW ;
TONG, E .
JOURNAL OF THEORETICAL BIOLOGY, 1962, 3 (03) :459-&
[3]   POTENTIAL ANTICANCER AGENTS .66. NON-CLASSICAL ANTIMETABOLITES .3. 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASE [J].
BAKER, BR ;
LEE, WW ;
ROSS, LO ;
TONG, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1961, 83 (17) :3713-&
[6]   NON-CLASSICAL ANTIMETABOLITES .7. BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS [J].
BAKER, BR .
JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1962, 5 (03) :654-&
[7]   POTENTIAL ANTICANCER AGENTS .50. NON-CLASSICAL ANTIMETABOLITES .2. SOME FACTORS IN THE DESIGN OF EXO-ALKYLATING ENZYME INHIBITORS, PARTICULARLY OF LACTIC DEHYDROGENASE [J].
BAKER, BR ;
LEE, WW ;
SKINNER, WA ;
MARTINEZ, AP ;
TONG, E .
JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1960, 2 (06) :633-657
[9]  
BAKER BR, 1959, CANCER CHEMOTERAPY
[10]  
BOYER PD, 1959, ENZYMES, P529